Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
07 03 2022
Historique:
received: 27 09 2021
accepted: 12 12 2021
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 9 4 2022
Statut: epublish

Résumé

Modest improvements in household water, sanitation, and hygiene (WASH) and typhoid vaccination can reduce typhoid risk in endemic settings. However, empiric evaluation of their combined impact is lacking. A total of 62,756 persons residing in 80 clusters in a Kolkata slum were allocated randomly 1:1 to either the typhoid Vi polysaccharide (ViPS) vaccine or hepatitis A (Hep A) vaccine. Surveillance was conducted for 2 years before and 2 years after vaccination. We classified households as having "better" or "not better" WASH, and calculated the prevalence of better WASH households in clusters using previously validated criteria. We evaluated the protection by better household WASH, better household WASH prevalence, and ViPS vaccination against typhoid in all cluster members present at baseline using Cox proportional hazard models. Overall, ViPS vaccination was associated with a 55% (P < 0.001; 95% CI, 35-69) reduction of typhoid risk and was similar regardless of better WASH in the residence. Living in a better WASH household was associated with a typhoid risk reduction of 31% (P = 0.16; 95% CI, -16 to 59) overall. The reduction was 48% (P = 0.05; 95% CI, -1 to 73) in Hep A clusters, 6% (P = 0.85; 95% CI, -82 to 51) in ViPS clusters, and 57% (P < 0.05; 95% CI, 15-78) in the population during the 2 years preceding the trial. These findings demonstrate a preventive association of better household WASH in the non-ViPS population, but, unexpectedly, an absence of additional protection from ViPS by better WASH in the ViPS population. This analysis highlights the importance of assessing the combination of WASH in conjunction with typhoid vaccines, and has implications for the evaluation of new-generation typhoid conjugate vaccines.

Identifiants

pubmed: 35385827
doi: 10.4269/ajtmh.21-1034
pii: tpmd211034
pmc: PMC8991341
doi:
pii:

Substances chimiques

Dietary Carbohydrates 0
Typhoid-Paratyphoid Vaccines 0
Water 059QF0KO0R

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1149-1155

Références

Clin Infect Dis. 2021 Jun 1;72(11):e720-e726
pubmed: 32964216
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
Bull World Health Organ. 2001;79(7):625-31
pubmed: 11477965
Demography. 2005 Feb;42(1):1-22
pubmed: 15782893
Lancet. 1987 Nov 21;2(8569):1165-9
pubmed: 2890805
Lancet Glob Health. 2017 Oct;5(10):e969
pubmed: 28911760
Bull World Health Organ. 1971;44(5):667-72
pubmed: 5316750
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Lancet Glob Health. 2014 Oct;2(10):e570-80
pubmed: 25304633
Lancet Infect Dis. 2019 Apr;19(4):369-381
pubmed: 30792131
Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S130-S137
pubmed: 30845337
N Engl J Med. 2009 Jul 23;361(4):335-44
pubmed: 19625715
N Engl J Med. 1987 Oct 29;317(18):1101-4
pubmed: 3657877

Auteurs

Justin Im (J)

International Vaccine Institute, Seoul, Republic of Korea.

Faisal Ahmmed (F)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Deok Ryun Kim (DR)

International Vaccine Institute, Seoul, Republic of Korea.

Sophie Kang (S)

International Vaccine Institute, Seoul, Republic of Korea.

Birkneh Tilahun Tadesse (BT)

International Vaccine Institute, Seoul, Republic of Korea.

Fahima Chowdhury (F)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Tasnuva Ahmed (T)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Asma Binte Aziz (AB)

International Vaccine Institute, Seoul, Republic of Korea.

Masuma Hoque (M)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Md Taufiqul Islam (MT)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Juyeon Park (J)

International Vaccine Institute, Seoul, Republic of Korea.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Xinxue Liu (X)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.

Dipika Sur (D)

National Institute of Cholera and Enteric Diseases, Kolkata, West Bengal, India.

Gideok Pak (G)

International Vaccine Institute, Seoul, Republic of Korea.

Hyon Jin Jeon (HJ)

International Vaccine Institute, Seoul, Republic of Korea.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Khalequ Zaman (K)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Ashraful Islam Khan (AI)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Firdausi Qadri (F)

International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.

Florian Marks (F)

International Vaccine Institute, Seoul, Republic of Korea.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
University of Antananarivo, Antananarivo, Madagascar.

Jerome H Kim (JH)

International Vaccine Institute, Seoul, Republic of Korea.

John D Clemens (JD)

International Vaccine Institute, Seoul, Republic of Korea.
International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
University of California Los Angeles Fielding School of Public Health, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH